Medical Device Law Weekly

Avant Immunotherapeutics, Inc. - Defense contract awarded for testing of plague/anthrax vaccine

BD Diagnostics - Strand displacement DNA amplification reviewed

BTG - New prostate cancer drug licensed to Cougar Biotechnology

Barcelona Clinical Hospital - Female liver transplant recipients have poorer psychosocial adjustment

Becton, Dickinson and Company - Drug delivery device maker reports 6% increase in revenue

Belfast City Hospital - Belfast scientists learn how best to target bowel cancer treatment

Bio-One Corporation - Acquisition revenue was $13.5M for alternative medicines company

Bioenvision, Inc. - Interim data reported from phase II trial of Clofarabine

Blue Cross Blue Shield, Rhode Island - Health groups call for Rhode Island insurer's president to resign

Brain Fingerprinting Laboratories - Promoter of 'brain fingerprinting' considers Colorado for training

Bristol-Myers Squibb Company - U.S. supply agreement signed for A1cNow diabetes monitor

Business Update - Alliance will offer consumer-driven health plan to Washington, DC-area employers

Business Update - Wyeth, MedImmune end FluMist partnership

CHRU Pontchaillou - Genes and gender seem to modulate iron homeostatis

CalbaTech, Inc. - Life sciences firm discloses intent to buy back common stock

Cancer Treatment - Gene mutation discovery could help treat lung cancer patients

Capitol Outcomes Research Inc. - Hepatitis A/B vaccine cost-effective substitute for hepatitis B vaccine

Caraco Pharmaceutical Laboratories - FDA grants approval for generic form of Remeron

Case Western Reserve University - Green tea polyphenol studied as possible cervical cell growth inhibitor

Catalan Institute of Oncology, Barcelona - Celiac disease not a risk factor for lymphoma

Cell Signaling Technology, Inc. - Antibody supply and license agreement signed for reagents

CellTran - Skin cell bandages for burns developed

Centocor, Inc. - FDA accepts BLA for Remicade

Cephalon Inc. - Vascular endothelial growth factor receptor kinase inhibitors staunch cancer

Cerus Corp. - MedImmune to codevelop therapeutic vaccine for cancer

Charles Universitym, Prague - PPAR-alpha deficiency does not alter insulin sensitivity in mice

Chiron Corporation - Biotech firm reports income of $0.22 per share

Chronogen, Inc. - Kees Been named to board of directors at pharmaceutical firm

Chung Shan University Hospital, Taichung - Thallium-201 SPET more accurate than CT or MRI detecting squamous cell carcinoma

aaiPharma Inc. - Pharmaceutical company appoints new president of pharmaceuticals division